002412 漢森製藥
按盤價 
10.790 -1.030 (-8.714%)
10.790 -1.030 (-8.714%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.515 | 8.643 | 10.572 | 10.630 | 9.219 |
| 總資產報酬率 ROA (%) | 4.151 | 7.561 | 9.020 | 8.861 | 7.615 |
| 投入資產回報率 ROIC (%) | 4.456 | 8.374 | 10.109 | 10.028 | 8.595 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.371 | 77.363 | 75.855 | 73.220 | 72.065 |
| 營業利潤率 (%) | 25.679 | 23.022 | 25.206 | 24.587 | 20.609 |
| 息稅前利潤/營業總收入 (%) | 25.808 | 23.040 | 25.319 | 23.855 | 20.201 |
| 淨利潤/營業總收入 (%) | 22.385 | 19.073 | 21.926 | 21.456 | 18.297 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.841 | 98.962 | 91.742 | 75.785 | 71.639 |
| 價值變動淨收益/利潤總額(%) | 19.025 | 3.434 | 4.766 | 27.850 | 50.979 |
| 營業外收支淨額/利潤總額(%) | 0.429 | -0.223 | -0.169 | -3.947 | -3.815 | 償債能力分析 |
| 流動比率 (X) | 14.791 | 4.584 | 3.528 | 2.521 | 2.276 |
| 速動比率 (X) | 12.004 | 3.861 | 2.828 | 1.871 | 1.627 |
| 資產負債率 (%) | 4.178 | 11.591 | 13.499 | 15.984 | 17.321 |
| 帶息債務/全部投入資本 (%) | -0.851 | 1.447 | 2.736 | 4.104 | 5.544 |
| 股東權益/帶息債務 (%) | -11,738.794 | 6,744.455 | 3,514.459 | 2,315.256 | 1,689.107 |
| 股東權益/負債合計 (%) | 2,293.647 | 762.749 | 640.793 | 525.633 | 477.337 |
| 利息保障倍數 (X) | 1,384.307 | 330.946 | 162.138 | 118.655 | 57.848 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 110.041 | 98.668 | 97.908 | 92.561 | 86.375 |
| 存貨周轉天數 (天) | 375.231 | 330.175 | 336.946 | 336.050 | 246.182 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 01/09/2026 11:06 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
